According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:
1. Trubridge (NASDAQ:TBRG)
Trubridge (NASDAQ:TBRG) is the #1 top health information service stock out of 55 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: C.
Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 17, which is -11 points lower than the health information service industry average of 28. Although this number is below the industry average, our proven quant model rates TBRG as a "A".
TBRG passed 6 out of 38 due diligence checks and has weak fundamentals. Trubridge has seen its stock return 55.58% over the past year, overperforming other health information service stocks by 106 percentage points.
2. Nutex Health (NASDAQ:NUTX)
Nutex Health (NASDAQ:NUTX) is the #2 top health information service stock out of 55 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Nutex Health (NASDAQ:NUTX) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: F, Financials: C, and AI: C.
Nutex Health (NASDAQ:NUTX) has a Due Diligence Score of 39, which is 11 points higher than the health information service industry average of 28.
NUTX passed 12 out of 33 due diligence checks and has average fundamentals. Nutex Health has seen its stock return 429.33% over the past year, overperforming other health information service stocks by 479 percentage points.
Nutex Health has an average 1 year
price target of $252.50, an upside of 147.16% from Nutex Health's current stock price of $102.16.
Nutex Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Nutex Health, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Definitive Healthcare (NASDAQ:DH)
The Component Grade breakdown for Definitive Healthcare (NASDAQ:DH) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: C, and AI: C.
Definitive Healthcare (NASDAQ:DH) has a Due Diligence Score of 14, which is -14 points lower than the health information service industry average of 28. Although this number is below the industry average, our proven quant model rates DH as a "B".
DH passed 4 out of 33 due diligence checks and has weak fundamentals. Definitive Healthcare has seen its stock lose -32.35% over the past year, overperforming other health information service stocks by 18 percentage points.
Definitive Healthcare has an average 1 year
price target of $4.70, an upside of 57.19% from Definitive Healthcare's current stock price of $2.99.
Definitive Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Definitive Healthcare, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.